Clinical Trial Update: Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating the safety and efficacy of statins in patients with chronic hepatitis C undergoing sofosbuvir/daclatasvir therapy, completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Metabolic Syndrome

Drugs mentioned

• Statins
• sofosbuvir/daclatasvir (sofosbuvir and daclatasvir)

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Hepatitis c, Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED